Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Strongbridge Biopharma plc (SBBP)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Mar-31-20Dec-31-19Sep-30-19
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Cash flows from operating activities:          
    Net loss  -40.2-44.2-45.1-42.1-52.7-43.7-49.543.6
    Adjustments to reconcile net loss income to net cash used in operating activities:          
        Stock-based compensation  8.27.97.47.17.28.08.69.1
        Amortization of intangible asset  5.05.05.05.05.05.05.05.4
        Change in fair value of warrant liability  -5.92.20.8-1.52.3-13.8-11.4-10.0
        Amortization of debt discounts and debt issuance costs  1.31.00.70.4    
        Accretion of discounts on marketable securities      -0.4-0.4-0.4 
        Depreciation  0.10.10.10.10.10.10.10.1
        Changes in operating assets and liabilities:          
            Accounts receivable  -0.7-0.2-0.50.53.51.2-0.7-0.8
            Inventory  0.20.11.10.91.52.41.63.5
            Prepaid expenses and other current assets  0.2-0.80.20.70.51.63.10.3
            Other assets  -0.1-0.10.10.40.70.7-0.8-1.0
            Accounts payable  -1.30.5-1.8-0.40.53.62.2-1.3
            Accrued and other liabilities  -0.8-7.7-6.0-5.7-3.9-6.4-2.6-12.3
                Net cash used in operating activities  -34.0-36.3-38.1-34.7-35.7-41.7-44.8-75.9
   
Cash flows from investing activities:          
    Sales and maturities of marketable securities      21.114.8  
    Purchases of property and equipment   0.0 0.0  -0.1-0.1
        Net cash (used in) provided by investing activities   6.3 40.828.3-5.9-20.8118.9
   
Cash flows from financing activities:          
    Payments related to tax withholding for net-share settled equity awards  -0.8-0.7 -0.4-0.4-0.1 -0.1
    Proceeds from long-term debt, net    19.39.39.5   
    Proceeds from exercise of stock options   0.1     0.2
        Net cash (used in) provided by financing activities  37.947.447.536.89.1-0.1 -71.4
   
Supplemental disclosures of cash flow information: Cash paid during the year for:          
    Interest  1.51.10.60.40.1   
    Income taxes other, net of refunds   2.00.70.70.5   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy